Published in J Appl Physiol (1985) on September 01, 1996
Con: All dwellers at high altitude are persons of impaired physical and mental powers: the view from the Himalayas. High Alt Med Biol (2013) 1.71
Hypoxic stress tolerance of the blind subterranean mole rat: expression of erythropoietin and hypoxia-inducible factor 1 alpha. Proc Natl Acad Sci U S A (2004) 1.17
Genetic variants in EPAS1 contribute to adaptation to high-altitude hypoxia in Sherpas. PLoS One (2012) 1.00
Our ancestral physiological phenotype: an adaptation for hypoxia tolerance and for endurance performance? Proc Natl Acad Sci U S A (1998) 0.86
The contribution of arterial blood gases in cerebral blood flow regulation and fuel utilization in man at high altitude. J Cereb Blood Flow Metab (2015) 0.82
Brain blood flow in Andean and Himalayan high-altitude populations: evidence of different traits for the same environmental constraint. J Cereb Blood Flow Metab (2010) 0.82
Cerebrovascular reactivity among native-raised high altitude residents: an fMRI study. BMC Neurosci (2011) 0.81
Altitude Adaptation: A Glimpse Through Various Lenses. High Alt Med Biol (2015) 0.80
Effects of Systemic Metabolic Fuels on Glucose and Lactate Levels in the Brain Extracellular Compartment of the Mouse. Front Neurosci (2017) 0.75
Rebuttal to pro statements. High Alt Med Biol (2013) 0.75
Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. JAMA (2001) 5.13
The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features. Neurology (2008) 4.78
Undersampled projection reconstruction applied to MR angiography. Magn Reson Med (2000) 3.93
Unifying theory of hypoxia tolerance: molecular/metabolic defense and rescue mechanisms for surviving oxygen lack. Proc Natl Acad Sci U S A (1996) 3.89
Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science (2000) 3.89
Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord (1997) 3.77
Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment. Neurobiol Aging (2005) 3.00
High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype. Arch Neurol (1998) 2.77
Histamine (?) toxicity from fish products. Adv Food Res (1978) 2.73
CSF biomarkers in frontotemporal lobar degeneration with known pathology. Neurology (2008) 2.43
Individual patient diagnosis of AD and FTD via high-dimensional pattern classification of MRI. Neuroimage (2008) 2.36
Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease: PET evidence of increased dopamine turnover. Ann Neurol (2001) 2.31
Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease. Neurology (2000) 2.27
Single base pair mutation analysis by PNA directed PCR clamping. Nucleic Acids Res (1993) 2.20
Rate of progression differs in frontotemporal dementia and Alzheimer disease. Neurology (2005) 2.18
Respiratory arrest after intramuscular ketamine in a 2-year-old child. Am J Emerg Med (1996) 2.14
Cognitive and motor assessment in autopsy-proven corticobasal degeneration. Neurology (2007) 2.09
Who provides patients with drug information? Br Med J (Clin Res Ed) (1987) 2.04
beta-Methyl-15-p-iodophenylpentadecanoic acid metabolism and kinetics in the isolated rat heart. Eur J Nucl Med (1989) 1.96
Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin. Diabetes Care (2001) 1.94
A systematic review of treatments for severe psoriasis. Health Technol Assess (2000) 1.93
The cortical localization of the lexicons. Positron emission tomography evidence. Brain (1992) 1.91
Novel CSF biomarkers for frontotemporal lobar degenerations. Neurology (2010) 1.89
Increased 8,12-iso-iPF2alpha-VI in Alzheimer's disease: correlation of a noninvasive index of lipid peroxidation with disease severity. Ann Neurol (2000) 1.79
Metabolic rate in the right amygdala predicts negative affect in depressed patients. Neuroreport (1998) 1.76
Loss of brain tau defines novel sporadic and familial tauopathies with frontotemporal dementia. Ann Neurol (2001) 1.75
Influence of the indigenous gastrointestinal microbial flora on duodenal alkaline phosphatase activity in mice. Infect Immun (1971) 1.69
Enhanced brain levels of 8,12-iso-iPF2alpha-VI differentiate AD from frontotemporal dementia. Neurology (2003) 1.66
Incorrect use of metered dose inhalers by medical personnel. Chest (1992) 1.65
In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease. Ann Neurol (2000) 1.65
Decay in quality of closed-chest compressions over time. Ann Emerg Med (1995) 1.64
The diabetes education study: a controlled trial of the effects of diabetes patient education. Diabetes Care (1986) 1.63
Accuracy of fingerstick glucose determination in patients receiving CPR. South Med J (1994) 1.62
Primary care physicians' practice patterns and diabetic retinopathy. Current levels of care. Arch Fam Med (1997) 1.62
Cortical and subcortical localization of response to pain in man using positron emission tomography. Proc Biol Sci (1991) 1.57
Genetic linkage studies in Alzheimer's disease families. Exp Neurol (1988) 1.57
Regulating ATP turnover rates over broad dynamic work ranges in skeletal muscles. J Appl Physiol (1985) (1992) 1.54
Evidence for transhemispheric diaschisis in unilateral stroke. Arch Neurol (1989) 1.54
The severe impairment battery: concurrent validity and the assessment of longitudinal change in Alzheimer's disease. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord (1997) 1.53
Glucose uptake by gliomas after treatment. A positron emission tomographic study. Arch Neurol (1989) 1.49
An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in Patients with Congestive Heart Failure. J Nucl Med (2001) 1.47
Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer's disease. Ann Neurol (1995) 1.46
Sensitivity and specificity of the neonatal brain-stem auditory evoked potential for hearing and language deficits in survivors of extracorporeal membrane oxygenation. J Pediatr (1997) 1.40
Amrinone as an antidote in experimental verapamil overdose. Acad Emerg Med (1996) 1.39
Age-related declines in nigral neuronal function correlate with motor impairments in rhesus monkeys. J Comp Neurol (1998) 1.39
Emergency department treatment of migraine, tension, and mixed-type headache. J Emerg Med (1995) 1.39
Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease. Proc Natl Acad Sci U S A (2009) 1.39
Superiority of visual versus computerized echocardiographic estimation of radionuclide left ventricular ejection fraction. Am Heart J (1989) 1.39
Amenorrhea in an ovulatory woman despite a normal uterine cavity: case report. Am J Obstet Gynecol (1989) 1.38
Technetium-94m-teboroxime: synthesis, dosimetry and initial PET imaging studies. J Nucl Med (1993) 1.38
Reproducibility of fluorine-18-6-fluorodopa positron emission tomography in normal human subjects. J Nucl Med (1994) 1.35
Myocardial free fatty acid and glucose use after carvedilol treatment in patients with congestive heart failure. Circulation (2001) 1.35
Corticobasal syndrome and primary progressive aphasia as manifestations of LRRK2 gene mutations. Neurology (2007) 1.33
Disseminated aspergillosis involving the brain: distribution and imaging characteristics. AJNR Am J Neuroradiol (1999) 1.32
Metabolic and work efficiencies during exercise in Andean natives. J Appl Physiol (1985) (1991) 1.31
Effect of peripheral catechol-O-methyltransferase inhibition on the pharmacokinetics and pharmacodynamics of levodopa in parkinsonian patients. Neurology (1994) 1.30
Stabilization of bovine trypsin by reductive methylation. Biochim Biophys Acta (1977) 1.29
Myoglobin diffusion in bovine heart muscle. Science (1983) 1.29
The measurement of antibody affinity: a comparison of five techniques utilizing a panel of monoclonal anti-DNP antibodies and the effect of high affinity antibody on the measurement of low affinity antibody. J Immunol Methods (1983) 1.28
Relations between PET-derived measures of thalamic glucose metabolism and EEG alpha power. Psychophysiology (1998) 1.27
Linkage analysis of familial Alzheimer disease, using chromosome 21 markers. Am J Hum Genet (1991) 1.26
The role of infant factors in postnatal depression and mother-infant interactions. Dev Med Child Neurol (1996) 1.26
Thalamic metabolic rate predicts EEG alpha power in healthy control subjects but not in depressed patients. Biol Psychiatry (1999) 1.25
Effects of hypocarbia on the development of cystic periventricular leukomalacia in premature infants treated with high-frequency jet ventilation. Pediatrics (1996) 1.25
The relationship between caregivers' global ratings of Alzheimer's disease patients' quality of life, disease severity, and the caregiving experience. J Am Geriatr Soc (2001) 1.25
Cerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology. Biochem Biophys Res Commun (1997) 1.24
A new internal pair production branching ratio of 90Y: the development of a non-destructive assay for 90Y and 90Sr. Appl Radiat Isot (2006) 1.24
The influence of previous exposure to environmental mycobacteria on the interferon-gamma response to bacille Calmette-Guérin vaccination in southern England and northern Malawi. Clin Exp Immunol (2006) 1.24
Failure of affinity maturation leads to increased susceptibility to immune complex glomerulonephritis. Immunology (1984) 1.21
Interferon-gamma and skin test responses of schoolchildren in southeast England to purified protein derivatives from Mycobacterium tuberculosis and other species of mycobacteria. Clin Exp Immunol (2003) 1.19
Ratings of personality change in patients being evaluated for memory disorders. Alzheimer Dis Assoc Disord (1991) 1.18
Pictorial review of glutamate excitotoxicity: fundamental concepts for neuroimaging. AJNR Am J Neuroradiol (2001) 1.18
Evaluation of the use of programmed instruction for patients maintained on Warfarin therapy. Am J Public Health (1972) 1.18
Criteria for demonstrating female sperm choice. Evolution (2000) 1.17
Mandatory assessment of patients over 75. BMJ (1991) 1.16
Hyperinsulinism and hyperammonemia syndrome: report of twelve unrelated patients. Pediatr Res (2001) 1.15
Patterns of referral and examination for retinopathy in pregnant women with diabetes by primary care physicians. Ophthalmic Epidemiol (1995) 1.13
Response of aged parkinsonian monkeys to in vivo gene transfer of GDNF. Neurobiol Dis (2009) 1.12
Autoxidation of oxymyoglobins. J Biol Chem (1969) 1.12
Influence of joint position on electromyographic and torque generation during maximal voluntary isometric contractions of the hamstrings and gluteus maximus muscles. J Orthop Sports Phys Ther (2001) 1.12
In vivo kinetics of [F-18]MEFWAY: a comparison with [C-11]WAY100635 and [F-18]MPPF in the nonhuman primate. Synapse (2010) 1.12
Age-dependent decline of dopamine D1 receptors in human brain: a PET study. Synapse (1998) 1.10
The brain at high altitude: hypometabolism as a defense against chronic hypoxia? J Cereb Blood Flow Metab (1994) 1.09
A new method of evaluating attachment representations in young school-age children: the Manchester Child Attachment Story Task. Attach Hum Dev (2000) 1.08
Evolution of female remating behaviour following experimental removal of sexual selection. Proc Biol Sci (2001) 1.08
Gray scale ultrasound evaluation of hepatic neoplasms: patterns and correlations. Radiology (1977) 1.08
Anxiolytic effects of Maxipost (BMS-204352) and retigabine via activation of neuronal Kv7 channels. J Pharmacol Exp Ther (2005) 1.08
Performance comparison of parameter estimation techniques for the quantitation of local cerebral blood flow by dynamic positron computed tomography. J Cereb Blood Flow Metab (1985) 1.07
Absence of estrogen receptor-beta expression in metastatic ovarian cancer. Obstet Gynecol (2000) 1.07